Therapeutic class | Kenya | Tanzania | Uganda | ||||||
---|---|---|---|---|---|---|---|---|---|
EMs n | Registered EMs n (%) | Local EMs n (%) | EMs n | Registered EMs n (%) | Local EMs n | EMs n | Registered EMs n (%) | Local EMs n (%) | |
Therapeutic classes common to all three countries and with some locally produced essential medicines | |||||||||
Anaesthetics | 14 | 14 (100) | 1 (7) | 35 | 11 (30) | None | 24 | 10 (42) | None |
Medicines for pain and palliative care | 17 | 17 (100) | 11(61) | 23 | 16 (69) | 2 (9) | 27 | 23 (85) | 6 (22) |
Anti-allergics and medicines used in anaphylaxis | 6 | 6 (100) | 3 (50) | 6 | 6 (100) | 2 (33) | 7 | 7 (100) | 2 (28) |
Antiepileptics/anticonvulsants | 9 | 8 (89) | 3 (33) | 7 | 6 (86) | None | 8 | 6 (75) | 1 (12) |
Anti-infective medicines | 90 | 77 (86) | 33(37) | 99 | 74 (75) | 11(11) | 110 | 82 (74) | 24(22) |
Anti-migraine medicines | 3 | 3 (100) | 1(33) | 5 | 4 (80) | None | 9 | 5 (55) | None |
Anti-neoplastic and immunosuppressive medicines | 52 | 38 (73) | 2 (4) | 43 | 19 (44) | None | 43 | 19 (44) | 1 (2) |
Anti-parkinsonism medicines | 3 | 1 (33) | 1 (33) | 4 | 1 (25) | None | 1 | None | None |
Medicines affecting the blood | 13 | 6 (46) | 2 (15) | 13 | 6 (46) | None | 11 | 5 (45) | 1 (9) |
Cardiovascular medicines | 21 | 18 (86) | 10(48) | 38 | 24 (63) | 1 (3) | 29 | 18 (62) | 1 (3) |
Dermatological medicines (Topical) | 20 | 15 (75) | 4 (20) | 20 | 11 (55) | 2 (10) | 18 | 10 (55) | 3 (17) |
Disinfectants and antiseptics | 5 | 3 (60) | 2 (40) | 5 | 1 (20) | 1 (20) | 8 | 4 (50) | 1 (12) |
Diuretics | 5 | 4 (80) | None | 4 | 3 (75) | None | 4 | 4 (100) | 1 (25) |
Gastrointestinal medicines | 10 | 9 (90) | 5 (50) | 28 | 13 (46) | 1 (3) | 18 | 14 (78) | 3 (17) |
Hormones, other endocrine medicines and contraceptives | 22 | 15 (68) | 2 (9) | 31 | 18 (58) | 1 (3) | 28 | 20 (71) | 1 (4) |
Ophthalmological preparations | 18 | 16 (89) | 3 (17) | 46 | 18 (39) | 1 (2) | 37 | 18 (49) | 3 (8) |
Peritoneal and haemodialysis solutions | None | n/a | n/a | None | n/a | n/a | None | n/a | n/a |
Medicines for mental and behavioural disorders | 20 | 14 (70) | 4 (20) | 25 | 13 (52) | None | 26 | 16 (62) | 1 (6) |
Medicines acting on the respiratory tract | 6 | 6 (100) | 1 (17) | 7 | 4 (57) | 1 (14) | 8 | 6 (75) | 1 (12) |
Solutions correcting water, electrolyte and acid–base disturbances | 9 | 8 (89) | 2 (22) | 7 | 5 (71) | None | 11 | 6 (54) | 4 (36) |
Vitamins and minerals | 7 | 3 (43) | 2 (28) | 14 | 2 (14) | 1 (7) | 10 | 4 (40) | 1 (10) |
Therapeutic classes common to all three countries and with no locally produced essential medicines | |||||||||
*Antidotes and other substances used in poisoning | 15 | 2 (13) | None | 9 | 1 (11) | None | 17 | 5 (29) | None |
*Blood products of human origin and plasma substitutes | 7 | 4 (57) | None | 7 | None | None | 4 | None | None |
*Diagnostic agents | 2 | None | None | 2 | 2 (100) | None | 6 | None | None |
*Immunologicals and vaccines | 20 | 18 (90) | None | 17 | 1 (6) | None | 22 | 7 (32) | None |
*Muscle relaxants (peripherally acting) and cholinesterase inhibitors | 6 | 5 (83) | None | 1 | 1 (100) | None | 7 | 4 (57) | None |
*Oxytocics and anti-oxytocics | 6 | 5 (89) | None | 6 | 6 (100) | None | 4 | 3 (75) | None |
*Ear, nose and throat medicines | 7 | 4 (57) | None | 8 | 3 (37) | None | 13 | 11 (85) | None |
Therapeutic classes unique to one or two countries and with no locally produced essential medicines | |||||||||
Specific medicines for neonatal care (Uganda/Kenya) | 5 | 2 (40) | None | X | X | X | 4 | 3 (75) | None |
Medicines for diseases of joints (Uganda/Kenya) | 7 | 5 (71) | None | X | X | X | 4 | 2 (50) | None |
Nutrition (Uganda/Kenya) | 4 | 1 (25) | None | X | X | X | 6 | 2 (33) | None |
Medicines for other conditions (Kenya) | 1 | None | None | X | X | X | X | X | X |
Medicines for neurosurgical use (Uganda) | X | X | X | X | X | X | 2 | None | None |
Total NEML medicines | 430 | 327(76) | 92(21) | 510 | 269 (53) | 24 (5) | 526 | 314 (60) | 55(10) |